364: Closing a zombie biotech, and Lilly's disappointing obesity readout
The Readout Loud
00:00
Intro
This chapter explores the recent shutdown of Third Harmonic Bio and its unmet operational goals. The discussion also covers disappointing results from Lilly and Vertex, highlighting the complexities of biotech endeavors and the bittersweet nature of failure in innovation.
Transcript
Play full episode
